The global market for Rabies Immune Globulin (Human) was estimated to be worth US$ 1500 million in 2023 and is forecast to a readjusted size of US$ 1973.9 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030

Rabies Immune Globulin (Human) - Market

The market for Rabies Immune Globulin (Human) is primarily driven by the incidence of rabies in different regions of the world. According to the World Health Organization, rabies is present in more than 150 countries, with an estimated 59,000 human deaths annually. The majority of these deaths occur in Asia and Africa, where access to post-exposure prophylaxis may be limited.

In addition, the market for Rabies Immune Globulin (Human) is also influenced by government policies and regulations related to rabies prevention and control. Many countries have established national vaccination programs and guidelines for post-exposure prophylaxis, which may include the use of Rabies Immune Globulin (Human).

Overall, the market for Rabies Immune Globulin (Human) is expected to continue to grow as awareness of rabies and the importance of post-exposure prophylaxis increases, particularly in regions with high incidence of the disease.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Rabies Immune Globulin (Human), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Rabies Immune Globulin (Human) by region & country, by Type, and by Application.

The Rabies Immune Globulin (Human) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rabies Immune Globulin (Human).

Market Segmentation

Scope of Rabies Immune Globulin (Human) - Market Report

Report Metric	Details
Report Name	Rabies Immune Globulin (Human) - Market
Forecasted market size in 2030	US$ 1973.9 million
CAGR	4.0%
Forecasted years	2024 - 2030
Segment by Type:	HyperRAB S/D KEDRAB
Segment by Application	Clinic Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, Grifols, Sanofi, Kamada, Bharat Serum, Bio Products Laboratory, Shanghai RAAS, Weiguang Bio, Shuanglin Bio, CBPO, CNBG, Sichuan Yuanda Shuyang, Kedrion Biopharma, Congruent Pharmachem, hualanbio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rabies Immune Globulin (Human) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Rabies Immune Globulin (Human) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Rabies Immune Globulin (Human) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Rabies Immune Globulin (Human) - Market size in 2030?

Ans: The Rabies Immune Globulin (Human) - Market size in 2030 will be US$ 1973.9 million.

Who are the main players in the Rabies Immune Globulin (Human) - Market report?

Ans: The main players in the Rabies Immune Globulin (Human) - Market are CSL Behring, Grifols, Sanofi, Kamada, Bharat Serum, Bio Products Laboratory, Shanghai RAAS, Weiguang Bio, Shuanglin Bio, CBPO, CNBG, Sichuan Yuanda Shuyang, Kedrion Biopharma, Congruent Pharmachem, hualanbio

What are the Application segmentation covered in the Rabies Immune Globulin (Human) - Market report?

Ans: The Applications covered in the Rabies Immune Globulin (Human) - Market report are Clinic, Hospital

What are the Type segmentation covered in the Rabies Immune Globulin (Human) - Market report?

Ans: The Types covered in the Rabies Immune Globulin (Human) - Market report are HyperRAB S/D, KEDRAB

1 Market Overview

1.1 Rabies Immune Globulin (Human) Product Introduction

1.2 Global Rabies Immune Globulin (Human) Market Size Forecast

1.2.1 Global Rabies Immune Globulin (Human) Sales Value (2019-2030)

1.2.2 Global Rabies Immune Globulin (Human) Sales Volume (2019-2030)

1.2.3 Global Rabies Immune Globulin (Human) Sales Price (2019-2030)

1.3 Rabies Immune Globulin (Human) Market Trends & Drivers

1.3.1 Rabies Immune Globulin (Human) Industry Trends

1.3.2 Rabies Immune Globulin (Human) Market Drivers & Opportunity

1.3.3 Rabies Immune Globulin (Human) Market Challenges

1.3.4 Rabies Immune Globulin (Human) Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Rabies Immune Globulin (Human) Players Revenue Ranking (2023)

2.2 Global Rabies Immune Globulin (Human) Revenue by Company (2019-2024)

2.3 Global Rabies Immune Globulin (Human) Players Sales Volume Ranking (2023)

2.4 Global Rabies Immune Globulin (Human) Sales Volume by Company Players (2019-2024)

2.5 Global Rabies Immune Globulin (Human) Average Price by Company (2019-2024)

2.6 Key Manufacturers Rabies Immune Globulin (Human) Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Rabies Immune Globulin (Human) Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Rabies Immune Globulin (Human)

2.9 Rabies Immune Globulin (Human) Market Competitive Analysis

2.9.1 Rabies Immune Globulin (Human) Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Rabies Immune Globulin (Human) Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Human) as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 HyperRAB S/D

3.1.2 KEDRAB

3.2 Global Rabies Immune Globulin (Human) Sales Value by Type

3.2.1 Global Rabies Immune Globulin (Human) Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Rabies Immune Globulin (Human) Sales Value, by Type (2019-2030)

3.2.3 Global Rabies Immune Globulin (Human) Sales Value, by Type (%) (2019-2030)

3.3 Global Rabies Immune Globulin (Human) Sales Volume by Type

3.3.1 Global Rabies Immune Globulin (Human) Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Rabies Immune Globulin (Human) Sales Volume, by Type (2019-2030)

3.3.3 Global Rabies Immune Globulin (Human) Sales Volume, by Type (%) (2019-2030)

3.4 Global Rabies Immune Globulin (Human) Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Clinic

4.1.2 Hospital

4.2 Global Rabies Immune Globulin (Human) Sales Value by Application

4.2.1 Global Rabies Immune Globulin (Human) Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Rabies Immune Globulin (Human) Sales Value, by Application (2019-2030)

4.2.3 Global Rabies Immune Globulin (Human) Sales Value, by Application (%) (2019-2030)

4.3 Global Rabies Immune Globulin (Human) Sales Volume by Application

4.3.1 Global Rabies Immune Globulin (Human) Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Rabies Immune Globulin (Human) Sales Volume, by Application (2019-2030)

4.3.3 Global Rabies Immune Globulin (Human) Sales Volume, by Application (%) (2019-2030)

4.4 Global Rabies Immune Globulin (Human) Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Rabies Immune Globulin (Human) Sales Value by Region

5.1.1 Global Rabies Immune Globulin (Human) Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Rabies Immune Globulin (Human) Sales Value by Region (2019-2024)

5.1.3 Global Rabies Immune Globulin (Human) Sales Value by Region (2025-2030)

5.1.4 Global Rabies Immune Globulin (Human) Sales Value by Region (%), (2019-2030)

5.2 Global Rabies Immune Globulin (Human) Sales Volume by Region

5.2.1 Global Rabies Immune Globulin (Human) Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Rabies Immune Globulin (Human) Sales Volume by Region (2019-2024)

5.2.3 Global Rabies Immune Globulin (Human) Sales Volume by Region (2025-2030)

5.2.4 Global Rabies Immune Globulin (Human) Sales Volume by Region (%), (2019-2030)

5.3 Global Rabies Immune Globulin (Human) Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Rabies Immune Globulin (Human) Sales Value, 2019-2030

5.4.2 North America Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Rabies Immune Globulin (Human) Sales Value, 2019-2030

5.5.2 Europe Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Rabies Immune Globulin (Human) Sales Value, 2019-2030

5.6.2 Asia Pacific Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Rabies Immune Globulin (Human) Sales Value, 2019-2030

5.7.2 South America Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Rabies Immune Globulin (Human) Sales Value, 2019-2030

5.8.2 Middle East & Africa Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Rabies Immune Globulin (Human) Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Rabies Immune Globulin (Human) Sales Value

6.2.1 Key Countries/Regions Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.2.2 Key Countries/Regions Rabies Immune Globulin (Human) Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.3.2 United States Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.4.2 Europe Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.5.2 China Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.5.3 China Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.6.2 Japan Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.7.2 South Korea Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.8.2 Southeast Asia Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Rabies Immune Globulin (Human) Sales Value, 2019-2030

6.9.2 India Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

6.9.3 India Rabies Immune Globulin (Human) Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CSL Behring

7.1.1 CSL Behring Company Information

7.1.2 CSL Behring Introduction and Business Overview

7.1.3 CSL Behring Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CSL Behring Rabies Immune Globulin (Human) Product Offerings

7.1.5 CSL Behring Recent Development

7.2 Grifols

7.2.1 Grifols Company Information

7.2.2 Grifols Introduction and Business Overview

7.2.3 Grifols Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Grifols Rabies Immune Globulin (Human) Product Offerings

7.2.5 Grifols Recent Development

7.3 Sanofi

7.3.1 Sanofi Company Information

7.3.2 Sanofi Introduction and Business Overview

7.3.3 Sanofi Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Sanofi Rabies Immune Globulin (Human) Product Offerings

7.3.5 Sanofi Recent Development

7.4 Kamada

7.4.1 Kamada Company Information

7.4.2 Kamada Introduction and Business Overview

7.4.3 Kamada Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Kamada Rabies Immune Globulin (Human) Product Offerings

7.4.5 Kamada Recent Development

7.5 Bharat Serum

7.5.1 Bharat Serum Company Information

7.5.2 Bharat Serum Introduction and Business Overview

7.5.3 Bharat Serum Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Bharat Serum Rabies Immune Globulin (Human) Product Offerings

7.5.5 Bharat Serum Recent Development

7.6 Bio Products Laboratory

7.6.1 Bio Products Laboratory Company Information

7.6.2 Bio Products Laboratory Introduction and Business Overview

7.6.3 Bio Products Laboratory Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bio Products Laboratory Rabies Immune Globulin (Human) Product Offerings

7.6.5 Bio Products Laboratory Recent Development

7.7 Shanghai RAAS

7.7.1 Shanghai RAAS Company Information

7.7.2 Shanghai RAAS Introduction and Business Overview

7.7.3 Shanghai RAAS Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Shanghai RAAS Rabies Immune Globulin (Human) Product Offerings

7.7.5 Shanghai RAAS Recent Development

7.8 Weiguang Bio

7.8.1 Weiguang Bio Company Information

7.8.2 Weiguang Bio Introduction and Business Overview

7.8.3 Weiguang Bio Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Weiguang Bio Rabies Immune Globulin (Human) Product Offerings

7.8.5 Weiguang Bio Recent Development

7.9 Shuanglin Bio

7.9.1 Shuanglin Bio Company Information

7.9.2 Shuanglin Bio Introduction and Business Overview

7.9.3 Shuanglin Bio Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Shuanglin Bio Rabies Immune Globulin (Human) Product Offerings

7.9.5 Shuanglin Bio Recent Development

7.10 CBPO

7.10.1 CBPO Company Information

7.10.2 CBPO Introduction and Business Overview

7.10.3 CBPO Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.10.4 CBPO Rabies Immune Globulin (Human) Product Offerings

7.10.5 CBPO Recent Development

7.11 CNBG

7.11.1 CNBG Company Information

7.11.2 CNBG Introduction and Business Overview

7.11.3 CNBG Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.11.4 CNBG Rabies Immune Globulin (Human) Product Offerings

7.11.5 CNBG Recent Development

7.12 Sichuan Yuanda Shuyang

7.12.1 Sichuan Yuanda Shuyang Company Information

7.12.2 Sichuan Yuanda Shuyang Introduction and Business Overview

7.12.3 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Offerings

7.12.5 Sichuan Yuanda Shuyang Recent Development

7.13 Kedrion Biopharma

7.13.1 Kedrion Biopharma Company Information

7.13.2 Kedrion Biopharma Introduction and Business Overview

7.13.3 Kedrion Biopharma Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Kedrion Biopharma Rabies Immune Globulin (Human) Product Offerings

7.13.5 Kedrion Biopharma Recent Development

7.14 Congruent Pharmachem

7.14.1 Congruent Pharmachem Company Information

7.14.2 Congruent Pharmachem Introduction and Business Overview

7.14.3 Congruent Pharmachem Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Congruent Pharmachem Rabies Immune Globulin (Human) Product Offerings

7.14.5 Congruent Pharmachem Recent Development

7.15 hualanbio

7.15.1 hualanbio Company Information

7.15.2 hualanbio Introduction and Business Overview

7.15.3 hualanbio Rabies Immune Globulin (Human) Sales, Revenue and Gross Margin (2019-2024)

7.15.4 hualanbio Rabies Immune Globulin (Human) Product Offerings

7.15.5 hualanbio Recent Development

8 Industry Chain Analysis

8.1 Rabies Immune Globulin (Human) Industrial Chain

8.2 Rabies Immune Globulin (Human) Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Rabies Immune Globulin (Human) Sales Model

8.5.2 Sales Channel

8.5.3 Rabies Immune Globulin (Human) Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Bio Products Laboratory

Sichuan Yuanda Shuyang

Kedrion Biopharma

Congruent Pharmachem

hualanbio

List of Tables

Table 1. Rabies Immune Globulin (Human) Market Trends

Table 2. Rabies Immune Globulin (Human) Market Drivers & Opportunity

Table 3. Rabies Immune Globulin (Human) Market Challenges

Table 4. Rabies Immune Globulin (Human) Market Restraints

Table 5. Global Rabies Immune Globulin (Human) Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Rabies Immune Globulin (Human) Revenue Market Share by Company (2019-2024)

Table 7. Global Rabies Immune Globulin (Human) Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Rabies Immune Globulin (Human) Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Rabies Immune Globulin (Human) Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Rabies Immune Globulin (Human) Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Rabies Immune Globulin (Human) Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Rabies Immune Globulin (Human)

Table 13. Global Rabies Immune Globulin (Human) Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin (Human) as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Rabies Immune Globulin (Human) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Rabies Immune Globulin (Human) Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Rabies Immune Globulin (Human) Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Rabies Immune Globulin (Human) Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Rabies Immune Globulin (Human) Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Rabies Immune Globulin (Human) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Rabies Immune Globulin (Human) Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Rabies Immune Globulin (Human) Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Rabies Immune Globulin (Human) Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Rabies Immune Globulin (Human) Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Rabies Immune Globulin (Human) Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Rabies Immune Globulin (Human) Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Rabies Immune Globulin (Human) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Rabies Immune Globulin (Human) Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Rabies Immune Globulin (Human) Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Rabies Immune Globulin (Human) Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Rabies Immune Globulin (Human) Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Rabies Immune Globulin (Human) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Rabies Immune Globulin (Human) Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Rabies Immune Globulin (Human) Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Rabies Immune Globulin (Human) Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Rabies Immune Globulin (Human) Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Rabies Immune Globulin (Human) Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Rabies Immune Globulin (Human) Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Rabies Immune Globulin (Human) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Rabies Immune Globulin (Human) Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Rabies Immune Globulin (Human) Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Rabies Immune Globulin (Human) Sales Value by Region (2019-2024) & (%)

Table 44. Global Rabies Immune Globulin (Human) Sales Value by Region (2025-2030) & (%)

Table 45. Global Rabies Immune Globulin (Human) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Rabies Immune Globulin (Human) Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Rabies Immune Globulin (Human) Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Rabies Immune Globulin (Human) Sales Volume by Region (2019-2024) & (%)

Table 49. Global Rabies Immune Globulin (Human) Sales Volume by Region (2025-2030) & (%)

Table 50. Global Rabies Immune Globulin (Human) Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Rabies Immune Globulin (Human) Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Rabies Immune Globulin (Human) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Rabies Immune Globulin (Human) Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Rabies Immune Globulin (Human) Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Rabies Immune Globulin (Human) Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Rabies Immune Globulin (Human) Sales Volume, (2025-2030) & (K Units)

Table 57. CSL Behring Company Information

Table 58. CSL Behring Introduction and Business Overview

Table 59. CSL Behring Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. CSL Behring Rabies Immune Globulin (Human) Product Offerings

Table 61. CSL Behring Recent Development

Table 62. Grifols Company Information

Table 63. Grifols Introduction and Business Overview

Table 64. Grifols Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Grifols Rabies Immune Globulin (Human) Product Offerings

Table 66. Grifols Recent Development

Table 67. Sanofi Company Information

Table 68. Sanofi Introduction and Business Overview

Table 69. Sanofi Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Sanofi Rabies Immune Globulin (Human) Product Offerings

Table 71. Sanofi Recent Development

Table 72. Kamada Company Information

Table 73. Kamada Introduction and Business Overview

Table 74. Kamada Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Kamada Rabies Immune Globulin (Human) Product Offerings

Table 76. Kamada Recent Development

Table 77. Bharat Serum Company Information

Table 78. Bharat Serum Introduction and Business Overview

Table 79. Bharat Serum Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Bharat Serum Rabies Immune Globulin (Human) Product Offerings

Table 81. Bharat Serum Recent Development

Table 82. Bio Products Laboratory Company Information

Table 83. Bio Products Laboratory Introduction and Business Overview

Table 84. Bio Products Laboratory Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Bio Products Laboratory Rabies Immune Globulin (Human) Product Offerings

Table 86. Bio Products Laboratory Recent Development

Table 87. Shanghai RAAS Company Information

Table 88. Shanghai RAAS Introduction and Business Overview

Table 89. Shanghai RAAS Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Shanghai RAAS Rabies Immune Globulin (Human) Product Offerings

Table 91. Shanghai RAAS Recent Development

Table 92. Weiguang Bio Company Information

Table 93. Weiguang Bio Introduction and Business Overview

Table 94. Weiguang Bio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Weiguang Bio Rabies Immune Globulin (Human) Product Offerings

Table 96. Weiguang Bio Recent Development

Table 97. Shuanglin Bio Company Information

Table 98. Shuanglin Bio Introduction and Business Overview

Table 99. Shuanglin Bio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Shuanglin Bio Rabies Immune Globulin (Human) Product Offerings

Table 101. Shuanglin Bio Recent Development

Table 102. CBPO Company Information

Table 103. CBPO Introduction and Business Overview

Table 104. CBPO Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. CBPO Rabies Immune Globulin (Human) Product Offerings

Table 106. CBPO Recent Development

Table 107. CNBG Company Information

Table 108. CNBG Introduction and Business Overview

Table 109. CNBG Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. CNBG Rabies Immune Globulin (Human) Product Offerings

Table 111. CNBG Recent Development

Table 112. Sichuan Yuanda Shuyang Company Information

Table 113. Sichuan Yuanda Shuyang Introduction and Business Overview

Table 114. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Sichuan Yuanda Shuyang Rabies Immune Globulin (Human) Product Offerings

Table 116. Sichuan Yuanda Shuyang Recent Development

Table 117. Kedrion Biopharma Company Information

Table 118. Kedrion Biopharma Introduction and Business Overview

Table 119. Kedrion Biopharma Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Kedrion Biopharma Rabies Immune Globulin (Human) Product Offerings

Table 121. Kedrion Biopharma Recent Development

Table 122. Congruent Pharmachem Company Information

Table 123. Congruent Pharmachem Introduction and Business Overview

Table 124. Congruent Pharmachem Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Congruent Pharmachem Rabies Immune Globulin (Human) Product Offerings

Table 126. Congruent Pharmachem Recent Development

Table 127. hualanbio Company Information

Table 128. hualanbio Introduction and Business Overview

Table 129. hualanbio Rabies Immune Globulin (Human) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. hualanbio Rabies Immune Globulin (Human) Product Offerings

Table 131. hualanbio Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Rabies Immune Globulin (Human) Downstream Customers

Table 135. Rabies Immune Globulin (Human) Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Rabies Immune Globulin (Human) Product Picture

Figure 2. Global Rabies Immune Globulin (Human) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Rabies Immune Globulin (Human) Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Rabies Immune Globulin (Human) Sales Volume (2019-2030) & (K Units)

Figure 5. Global Rabies Immune Globulin (Human) Sales Price (2019-2030) & (US$/Unit)

Figure 6. Rabies Immune Globulin (Human) Report Years Considered

Figure 7. Global Rabies Immune Globulin (Human) Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Rabies Immune Globulin (Human) Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Rabies Immune Globulin (Human) Revenue in 2023

Figure 10. Rabies Immune Globulin (Human) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. HyperRAB S/D Picture

Figure 12. KEDRAB Picture

Figure 13. Global Rabies Immune Globulin (Human) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Rabies Immune Globulin (Human) Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Rabies Immune Globulin (Human) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Rabies Immune Globulin (Human) Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Rabies Immune Globulin (Human) Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Clinic

Figure 19. Product Picture of Hospital

Figure 20. Global Rabies Immune Globulin (Human) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Rabies Immune Globulin (Human) Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Rabies Immune Globulin (Human) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Rabies Immune Globulin (Human) Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Rabies Immune Globulin (Human) Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Rabies Immune Globulin (Human) Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Rabies Immune Globulin (Human) Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Rabies Immune Globulin (Human) Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Rabies Immune Globulin (Human) Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Rabies Immune Globulin (Human) Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Rabies Immune Globulin (Human) Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Rabies Immune Globulin (Human) Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Rabies Immune Globulin (Human) Sales Volume (%), (2019-2030)

Figure 37. United States Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 43. China Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 45. China Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 55. India Rabies Immune Globulin (Human) Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Rabies Immune Globulin (Human) Sales Value by Type (%), 2023 VS 2030

Figure 57. India Rabies Immune Globulin (Human) Sales Value by Application (%), 2023 VS 2030

Figure 58. Rabies Immune Globulin (Human) Industrial Chain

Figure 59. Rabies Immune Globulin (Human) Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Combined Polio Vaccine Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12Q18734

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Amebiasis Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-38D9688

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Pseudorabies Virus Vaccine Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-14B9979

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Malaria Rapid Diagnostic Device Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-16B9848

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions